Answer
Mar 27, 2025 - 04:09 PM
XTANDI (enzalutamide) is typically prescribed to men with prostate cancer and is taken as long as it continues to be effective and the patient can tolerate the side effects. The duration of treatment varies for each individual based on their response and overall health. It's crucial for patients to have regular consultations with their healthcare provider to assess the treatment's effectiveness and any potential side effects.
